_________________
| ALARIS MEDICAL, INC. | ||
| (Exact name of registrant as specified in its charter) | ||
| Delaware | 1-10207 | 13-3492624 |
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation or organization) | Identification Number) | |
| |
||
| 10221 Wateridge Circle San Diego, CA 92121-1579 |
||
| (Address, including zip code, of registrant’s principal executive offices) | ||
| |
||
| (858) 458-7000 | ||
| Registrant’s telephone number, including area code | ||
Page 1 of 6
| On May 23, 2003, ALARIS Medical, Inc. and its wholly-owned operating subsidiary, ALARIS Medical Systems, Inc., announced today that each has commenced a cash tender offer and consent solicitation for all of its outstanding bonds in connection with a proposed recapitalization of both companies. The press release is attached as Exhibit 99.1. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ALARIS MEDICAL, INC. |
| Date: May 23, 2003 |
/s/DAVID L. SCHLOTTERBECK ———————————————— David L. Schlotterbeck President and Chief Executive Officer |
Exhibit
99.1 Press release of ALARIS Medical, Inc., dated May 23, 2003.